维普中文期刊产品整合服务
9篇 您的检索式:作者名="Brunetto AT"
    题名 作者 年代 出处 被引量
1Phase I trial of a selective p-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies 显示文摘Yap T A Olmos D Brunetto AT 2011J Clin Oncol2011,29,10:1
2Survivin as apredictive biomarker of complete pathologic response toneoadjuvant chemotherapy in patients with stage II andstage HI breast cancer显示文摘Petrarca CR Brunetto AT Duval V? 2011Clin Breast Cancer2011,11,2:1
3Neurokinin-1 re-ceptor antagonists for chemotherapy-induced nausea and vomi-ting: a systematic review 显示文摘DOS SL SOUZA FH BRUNETTO AT 2012J Natl Cancer Inst2012,104,:1
4Neurokinin- 1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review显示文摘Dos Santos LV Souza FH Brunetto AT 2012J Natl Cancer Inst2012,104,17:1
5Survivin as a predic- tive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage Ⅱ and stage Ⅲ breast cancer 显示文摘Petrarca CR Brunetto AT Duval V 2011Clin Breast Cancer2011,11,2:1
6Current and emerging molecular targets in glioma 显示文摘Roesler R Brunetto AT Abujamra AL 2010Expert Rev Anticancer Ther2010,10,11:1
7Phase 1 trial of a selectivec MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies显示文摘Yap TA Olmos D Brunetto AT 2011J Clin Oncol2011,29,12:1
8First-in-human,phar-macokinetic and pharmacodynamic phase I study of Res-minostat,an oral histone deacetylase inhibitor, in patients with advanced solid tumors显示文摘Brunetto AT Ang JE Lal R 2013Clin Cancer Res2013,19,19:1
9Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting:a systematic review显示文摘dos Santos LV Souza FH Brunetto AT 2012J Natl Cancer Inst2012,104,17:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费